As of May 2024 InnovAge has a market cap of $0.50 Billion. This makes InnovAge the world's 6023th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.50 B | -38.29% |
2023 | $0.81 B | -16.24% |
2022 | $0.97 B | 43.66% |
2021 | $0.67 B |
On May 18th, 2024 the market cap of InnovAge was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Merck MRK | $332.27 B | 65,939.08% | ๐บ๐ธ USA |
Cocrystal Pharma
COCP | $19.83 M | -96.06% | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | $14.57 M | -97.10% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | $26.63 B | 5,193.02% | ๐ฎ๐ช Ireland |